Merger Agreements in the Biotechnology Industry

656 Contracts & Agreements

Browse by Company

AbbVie Inc. (2 contracts)
ABEONA THERAPEUTICS INC. (4)
ACCELERON PHARMA INC (1)
ACHIEVE LIFE SCIENCES, INC. (3)
Acorda Therapeutics (3)
Adamas Pharmaceuticals Inc (1)
Adaptimmune Therapeutics PLC (2)
Adhera Therapeutics, Inc. (2)
ADiTx Therapeutics, Inc. (10)
ADMA BIOLOGICS, INC. (1)
ADURO BIOTECH, INC. (3)
Advaxis, Inc. (4)
Aeglea BioTherapeutics, Inc. (3)
AgeX Therapeutics, Inc. (2)
AILERON THERAPEUTICS INC (1)
Aimmune Therapeutics, Inc. (1)
AKCEA THERAPEUTICS, INC. (1)
Akebia Therapeutics, Inc. (2)
Akouos, Inc. (1)
ALBIREO PHARMA, INC. (1)
Aldeyra Therapeutics, Inc. (1)
Alexion Pharmaceuticals (9)
Alkermes plc. (1)
Alliqua BioMedical, Inc. (9)
Allovir, Inc. (1)
Alpha Healthcare Acquisition Corp. (1)
ALPINE IMMUNE SCIENCES, INC. (2)
Altimmune, Inc. (4)
Amgen Inc. (8)
AMICUS THERAPEUTICS, INC. (5)
AmpliPhi Biosciences Corp (3)
Anchiano Therapeutics Ltd. (1)
Anika Therapeutics (2)
APPLIED GENETIC TECHNOLOGIES CORP (1)
Applied Molecular Transport Inc. (1)
Aprea Therapeutics, Inc. (1)
AQUINOX PHARMACEUTICALS, INC (1)
Aravive, Inc. (1)
ARCA biopharma, Inc. (6)
ARENA PHARMACEUTICALS INC (1)
ARROWHEAD PHARMACEUTICALS, INC. (2)
Arsanis, Inc. (3)
ARYA Sciences Acquisition Corp II (3)
ASSEMBLY BIOSCIENCES, INC. (1)
Athenex, Inc. (1)
AVEO PHARMACEUTICALS INC (1)
Avid Bioservices, Inc. (2)
AVROBIO, Inc. (1)
Ayala Pharmaceuticals, Inc. (1)
AzurRx BioPharma, Inc. (2)
Beam Therapeutics Inc. (1)
Big Cypress Acquisition Corp. (1)
BioCardia, Inc. (4)
BIOCRYST PHARMACEUTICALS INC (1)
Biogen Inc. (2)
Biohaven Pharmaceutical Holding Co Ltd. (3)
BioRestorative Therapies, Inc. (1)
BIOSPECIFICS TECHNOLOGIES CORP (1)
BIOTIME INC (2)
BIOVIE INC. (1)
BIOXYTRAN, INC (2)
Bison Capital Acquisition Corp. (4)
Blueprint Medicines Corp (1)
Bone Biologics Corp (2)
BridgeBio Pharma, Inc. (2)
CALADRIUS BIOSCIENCES, INC. (4)
Calyxt, Inc. (2)
CANCER GENETICS, INC (4)
CAPRICOR THERAPEUTICS, INC. (4)
CAPSTAR SPECIAL PURPOSE ACQUISITION CORP. (2)
CareDx, Inc. (1)
CASI Pharmaceuticals, Inc. (2)
CASTLE BIOSCIENCES INC (2)
CATABASIS PHARMACEUTICALS INC (1)
CATALYST BIOSCIENCES, INC. (3)
CATALYST PHARMACEUTICALS, INC. (1)
Celldex Therapeutics, Inc. (1)
Cellectar Biosciences, Inc. (1)
Cellular Biomedicine Group, Inc. (5)
Centessa Pharmaceuticals Ltd (1)
Century Therapeutics, Inc. (1)
Chanticleer Holdings, Inc. (4)
Chardan Healthcare Acquisition 2 Corp. (2)
Chardan Healthcare Acquisition Corp. (5)
Checkmate Pharmaceuticals, Inc. (1)
ChemoCentryx, Inc. (1)
CHIMERIX INC (1)
CLEVELAND BIOLABS INC (1)
CM Life Sciences III Inc. (3)
Coherus BioSciences, Inc. (2)
Comera Life Sciences Holdings, Inc. (1)
Conatus Pharmaceuticals Inc. (1)
CONCERT PHARMACEUTICALS, INC. (1)
Constellation Alpha Capital Corp. (1)
CONSTELLATION PHARMACEUTICALS INC (1)
Corbus Pharmaceuticals Holdings, Inc. (1)
Cortexyme, Inc. (1)
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (2)
CTD HOLDINGS INC (4)
CTI BIOPHARMA CORP (2)
Cullinan Oncology, LLC (1)
Cybrdi, Inc. (1)
CytoDyn Inc. (1)
CYTRX CORP (1)
Decibel Therapeutics, Inc. (1)
Deciphera Pharmaceuticals, Inc. (3)
DelMar Pharmaceuticals, Inc. (5)
Dermira, Inc. (1)
Dicerna Pharmaceuticals Inc (1)
Diffusion Pharmaceuticals Inc. (6)
Digital Development Partners, Inc. (2)
Dynamics Special Purpose Corp. (2)
Edge Therapeutics, Inc. (4)
Eidos Therapeutics, Inc. (1)
Eiger BioPharmaceuticals, Inc. (4)
Eliem Therapeutics, Inc. (2)
Emerald Bioscience, Inc. (2)
Emergent BioSolutions Inc. (2)
Entasis Therapeutics Holdings Inc. (1)
Environmental Impact Acquisition Corp (2)
Epizyme, Inc. (1)
Equillium, Inc. (2)
Erasca, Inc. (1)
EVOLUTIONARY GENOMICS, INC. (2)
EXACT SCIENCES CORP (4)
Exelixis (1)
EXICURE, INC. (2)
Fibrocell Science, Inc. (1)
FIVE PRIME THERAPEUTICS INC (1)
Flex Pharma, Inc. (3)
Flexion Therapeutics Inc (1)
FLUOROPHARMA MEDICAL, INC. (2)
Forma Therapeutics Holdings, Inc., (1)
Fortress Biotech, Inc. (3)
Forty Seven, Inc. (1)
Frequency Therapeutics, Inc. (1)
FS Development Corp. (2)
FS Development Corp. II (3)
G1 Therapeutics, Inc. (1)
Galera Therapeutics, Inc. (1)
Gemphire Therapeutics Inc. (2)
Gene Biotherapeutics, Inc. (2)
GeoVax Labs, Inc. (2)
Gilead Sciences (12)
Global Blood Therapeutics, Inc. (1)
GLYCOMIMETICS INC (1)
Graphite Bio, Inc. (7)
GT Biopharma, Inc. (1)
GTX INC (2)
GX Acquisition Corp. (2)
HALOZYME THERAPEUTICS INC (1)
Harpoon Therapeutics, Inc. (1)
HEAT BIOLOGICS, INC. (1)
HedgePath Pharmaceuticals, Inc. (1)
HilleVax, Inc. (1)
HISTOGENICS CORP (2)
Homology Medicines, Inc. (2)
Icosavax, Inc. (1)
IDERA PHARMACEUTICALS, INC. (3)
Imago BioSciences, Inc. (1)
Immix Biopharma, Inc. (1)
IMMUNE PHARMACEUTICALS INC (5)
ImmunoCellular Therapeutics, Ltd. (1)
IMMUNOGEN INC (1)
Immunome Inc. (1)
IMMUNOMEDICS INC (1)
Incyte (2)
Inhibrx, Inc. (1)
INOVIO PHARMACEUTICALS, INC. (1)
INSMED Inc (1)
Inspyr Therapeutics, Inc. (1)
Intec Pharma Ltd. (2)
INTERCEPT PHARMACEUTICALS, INC. (1)
INTREXON CORP (2)
Invitae Corp (11)
IONIS PHARMACEUTICALS INC (1)
IOVANCE BIOTHERAPEUTICS, INC. (1)
Isoray, Inc. (4)
Jounce Therapeutics, Inc. (1)
Kadmon Holdings, Inc. (1)
Karuna Therapeutics, Inc. (1)
KBL MERGER CORP. IV (4)
Kindred Biosciences, Inc. (2)
Kinnate Biopharma Inc. (1)
Kura Oncology, Inc. (2)
LA JOLLA PHARMACEUTICAL CO (7)
LEAP THERAPEUTICS, INC. (1)
Leisure Acquisition Corp. (2)
LifeSci Acquisition Corp. (2)
Ligand Pharmaceuticals Incorporated (16)
LogicBio Therapeutics, Inc. (1)
Lyell Immunopharma, Inc. (1)
MADRIGAL PHARMACEUTICALS, INC. (1)
Magenta Therapeutics, Inc. (1)
MATEON THERAPEUTICS INC (4)
Matinas BioPharma Holdings, Inc. (2)
MEDICINOVA INC (1)
Medovex Corp. (2)
MEI Pharma, Inc. (1)
MeiraGTx Holdings plc (2)
Metacrine, Inc. (1)
Millendo Therapeutics, Inc. (3)
MiMedx Group, Inc. (4)
Minerva Neurosciences, Inc. (1)
MIRAGEN THERAPEUTICS, INC. (2)
Mirati Therapeutics, Inc. (1)
Molecular Templates, Inc. (1)
Moleculin Biotech, Inc. (1)
Momenta Pharmaceuticals, Inc. (1)
Morphic Holding, Inc. (1)
Myovant Sciences Ltd. (1)
Myriad Genetics, Inc. (3)
NantKwest, Inc. (4)
Neurotrope, Inc. (6)
NEWLINK GENETICS CORP (3)
NTN BUZZTIME INC (1)
NUTRA PHARMA CORP (1)
Ohr Pharmaceutical Inc (3)
Olivia Ventures, Inc. (1)
OncBioMune Pharmaceuticals, Inc (2)
OncoCyte Corp (4)
OPGEN INC (1)
Ophthotech Corp. (1)
Opko Health, Inc. (5)
Organogenesis Holdings Inc. (13)
ORGANOVO HOLDINGS, INC. (6)
Orgenesis Inc. (1)
Oyster Point Pharma, Inc. (1)
Pfenex Inc. (1)
PIERIS PHARMACEUTICALS, INC. (1)
PORTOLA PHARMACEUTICALS INC (1)
Poseida Therapeutics, Inc. (3)
Prevail Therapeutics Inc. (1)
Principia Biopharma Inc. (1)
Progenics Pharmaceuticals, Inc. (2)
Prometheus Biosciences, Inc. (1)
Protagenic Therapeutics, Inc. (5)
Protalix BioTherapeutics, Inc. (1)
PROTEON THERAPEUTICS INC (2)
PROTEOSTASIS THERAPEUTICS, INC. (5)
PTC THERAPEUTICS, INC. (1)
PUMA BIOTECHNOLOGY, INC. (1)
Qrons Inc. (1)
Radius Health, Inc. (2)
Rasna Therapeutics Inc. (2)
REGENXBIO Inc. (1)
Relay Therapeutics, Inc. (1)
Retrophin, Inc. (1)
Revolution Medicines, Inc. (3)
REXAHN PHARMACEUTICALS, INC. (3)
Rezolute, Inc. (1)
RITTER PHARMACEUTICALS INC (1)
ROCKET PHARMACEUTICALS, INC. (2)
Sana Biotechnology, Inc. (4)
SANGAMO THERAPEUTICS, INC (1)
Sarepta Therapeutics, Inc. (1)
Savara Inc (3)
SEATTLE GENETICS INC (2)
SELLAS Life Sciences Group, Inc. (2)
Sesen Bio, Inc. (1)
Sierra Oncology, Inc. (1)
Sigilon Therapeutics, Inc. (1)
Silverback Therapeutics, Inc. (3)
SOLENO THERAPEUTICS INC (1)
Solid Biosciences Inc. (5)
Sorrento Therapeutics, Inc. (12)
Spectrum Pharmaceuticals, Inc. (4)
SPHERIX INC (5)
Spinning Eagle Acquisition Corp. (4)
Spring Bank Pharmaceuticals, Inc. (3)
Sun BioPharma, Inc. (4)
SUNESIS PHARMACEUTICALS INC (1)
Surface Oncology, Inc. (1)
SYNLOGIC, INC. (4)
Synthetic Biologics, Inc. (1)
Syros Pharmaceuticals, Inc. (1)
Talaris Therapeutics, Inc. (1)
TCR2 THERAPEUTICS INC. (1)
TENAX THERAPEUTICS, INC. (1)
Therapeutics Acquisition Corp. (1)
Tocagen Inc (1)
Translate Bio, Inc. (1)
Turning Point Therapeutics, Inc. (1)
TYME TECHNOLOGIES, INC. (1)
Ultragenyx Pharmaceutical Inc. (1)
United Therapeutics Corp (1)
Unum Therapeutics Inc. (1)
Vaccitech plc (3)
Vaxart, Inc. (5)
VERACYTE, INC. (2)
Vertex Pharmaceuticals Inc (2)
VICAL INC (2)
Viela Bio, Inc. (1)
Vir Biotechnology, Inc. (1)
VistaGen Therapeutics, Inc. (2)
VITRO DIAGNOSTICS INC (1)
WINDTREE THERAPEUTICS INC (1)
XOMA Corp (1)
ZAFGEN, INC. (2)
ZIOPHARM ONCOLOGY INC (1)

Recent Contracts

Category

Company

Industry

Jur. Jurisdiction

Filed

Merger Agreement and Plan of Reorganization, dated as of January 8, 2021 by and among GX Acquisition Corp., Alpha First Merger Sub, Inc., Alpha Second Merger Sub LLC and...

Merger Agreements

GX Acquisition Corp.

Biotechnology

DE

2021

Agreement and Plan of Merger among the Company, Primary Merger Sub, Inc. and First Person, Ltd

Merger Agreements

Qrons Inc.

Biotechnology

2025

Agreement and Plan of Merger, dated as of December 30, 2024 by and among Galera, Grape Merger Sub I, Inc., Grape Merger Sub II, LLC and Nova

Merger Agreements

Galera Therapeutics, Inc.

Biotechnology

2024

Amendment to Agreement and Plan of Merger dated as of December 18, 2024 by and among Cyclo Therapeutics, Inc. and Rafael Holdings, Inc

Merger Agreements

CTD HOLDINGS INC

Biotechnology

2024

Agreement and Plan of Merger, dated December 11, 2024, by and among TuHURA, Kineta, the Merger Subs and the Stockholders Representative

Merger Agreements

DelMar Pharmaceuticals, Inc.

2024

AGREEMENT AND PLAN OF MERGER among TUHURA BIOSCIENCES, INC., HURA MERGER SUB I, INC. HURA MERGER SUB II, LLC KINETA, INC. and CRAIG PHILIPS, solely in his capacity as STOCKHOLDERS...

Merger Agreements

PROTEOSTASIS THERAPEUTICS, INC.

2024

Agreement and Plan of Merger, dated as of November 25, 2024, by and among Poseida Therapeutics, Inc., Roche Holdings, Inc. and Blue Giant Acquisition Corp

Merger Agreements

Poseida Therapeutics, Inc.

2024

Amendment No. 4 to Amended and Restated Merger Agreement

Merger Agreements

ADiTx Therapeutics, Inc.

2024

Agreement and Plan of Merger, dated as of November 7 2024, by and among AlloVir, Inc., Aurora Merger Sub, Inc. and Kalaris Therapeutics, Inc

Merger Agreements

Allovir, Inc.

2024

Agreement and Plan of Merger, dated as of November 6, 2024, by and among Space Finco, Inc., a Delaware corporation, Space Mergerco, Inc., a Delaware corporation, and Avid...

Merger Agreements

Avid Bioservices, Inc.

2024

Agreement and Plan of Merger and Reorganization, dated as of October 28, 2024, by and among GlycoMimetics Biopharma, Inc., Gemini Merger Sub Corp., Gemini Merger Sub II, LLC and...

Merger Agreements

GLYCOMIMETICS INC

2024

Agreement and Plan of Merger, dated as of October 24, 2024, by and among ImmPACT Bio USA Inc., Lyell Immunopharma, Inc., Inspire Merger Sub Inc. and WT Representative LLC, solely...

Merger Agreements

Lyell Immunopharma, Inc.

2024

Agreement and Plan of Merger, by and among Double Point Ventures LLC, DPV Parent, Inc., DPV MergerSub, Inc. and Lumos Pharma, Inc., dated October 22, 2024

Merger Agreements

NEWLINK GENETICS CORP

2024

Waiver Agreement to Agreement and Plan of Merger, dated as of October 18, 2024, by and among Kintara Therapeutics, Inc., Kayak Mergeco, Inc., and TuHURA Biosciences, Inc

Merger Agreements

DelMar Pharmaceuticals, Inc.

2024

Amendment No. 3 to Amended and Restated Merger Agreement

Merger Agreements

ADiTx Therapeutics, Inc.

2024

Waiver Agreement to Agreement and Plan of Merger, dated as of September 25, 2024, by and among Kintara Therapeutics, Inc., Kayak Mergeco, Inc., and TuHURA Biosciences, Inc

Merger Agreements

DelMar Pharmaceuticals, Inc.

2024

Amendment No. 2 to Amended and Restated Agreement and Plan of Merger dated as of September 6, 2024, by and among Aditxt, Inc., Adifem, Inc. and Evofem Biosciences, Inc

Merger Agreements

ADiTx Therapeutics, Inc.

2024

Agreement and Plan of Merger, dated as of August 21, 2024, by and among the Company, Rafael, First Merger Sub and Second Merger Sub

Merger Agreements

CTD HOLDINGS INC

2024

Amendment No. 1 to Amended and Restated Merger Agreement

Merger Agreements

ADiTx Therapeutics, Inc.

2024

Agreement and Plan of Merger, dated as of August 6, 2024, among the Company, Parent and Purchaser (pursuant to Item 601(a)(5) of Regulation S-K, the Company hereby agrees to...

Merger Agreements

G1 Therapeutics, Inc.

2024

Agreement and Plan of Merger, dated as of July 23, 2024, by and among Pieris Pharmaceuticals, Inc., Polo Merger Sub, Inc. and Palvella Therapeutics, Inc

Merger Agreements

PIERIS PHARMACEUTICALS, INC.

2024

Amended and Restated Agreement and Plan of Merger among Aditxt, Inc., Adifem, Inc. f/k/a Adicure, Inc. and Evofem Biosciences, Inc. dated as of July 12, 2024

Merger Agreements

ADiTx Therapeutics, Inc.

2024

Agreement and Plan of Merger, by and among Morphic Holding, Inc., Eli Lilly and Company and Rainier Acquisition Corporation, dated July 7, 2024

Merger Agreements

Morphic Holding, Inc.

2024

Certificate of Ownership and Merger

Merger Agreements

Immix Biopharma, Inc.

2024

Reinstatement and Fourth Amendment to the Merger Agreement dated May 2, 2024

Merger Agreements

ADiTx Therapeutics, Inc.

2024

Agreement and Plan of Merger, dated as of April 29, 2024, by and among Ono Pharmaceutical Co., Ltd., Topaz Merger Sub, Inc. and Deciphera Pharmaceuticals, Inc

Merger Agreements

Deciphera Pharmaceuticals, Inc.

2024

Agreement and Plan of Merger, dated April 11, 2024, by and among the Company and the other parties thereto

Merger Agreements

Century Therapeutics, Inc.

2024

Agreement and Plan of Merger and Reorganization, dated as of April 10, 2024, by and among Eliem Therapeutics, Inc., Tango Merger Sub, Inc., Tenet Medicines, Inc. and, solely in...

Merger Agreements

Eliem Therapeutics, Inc.

2024

Agreement and Plan of Merger by and among Alpine Immune Sciences, Inc., Vertex Pharmaceuticals Incorporated and Adams Merger Sub, Inc., dated April 10, 2024

Merger Agreements

ALPINE IMMUNE SCIENCES, INC.

2024

Agreement and Plan of Merger and Reorganization, dated as of April 3, 2024, by and among ARCA biopharma, Inc., Atlas Merger Sub Corp., Atlas Merger Sub II LLC and Oruka...

Merger Agreements

ARCA biopharma, Inc.

2024

Agreement and Plan of Merger, dated as of April 2, 2024, by and among Kintara Therapeutics, Inc., Kayak Mergeco, Inc., and TuHURA Biosciences, Inc

Merger Agreements

DelMar Pharmaceuticals, Inc.

2024

Agreement and Plan of Merger and Reorganization

Merger Agreements

Emerald Bioscience, Inc.

2024

Agreement and Plan of Merger, dated March 13, 2024, by and among First Wave BioPharma, Inc. IMMUNO Merger Sub I, Inc., IMMUNO Merger Sub II, LLC, and ImmunogenX, Inc

Merger Agreements

AzurRx BioPharma, Inc.

2024

Form of Merger Warrant

Merger Agreements

Chardan Healthcare Acquisition Corp.

2024

Agreement and Plan of Merger, dated March 6, 2024, by and among BiomX Inc., BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc

Merger Agreements

Chardan Healthcare Acquisition Corp.

2024

Third Amendment to Agreement and Plan of Merger dated as of February 29, 2024, by and among Aditxt, Inc., Adicure, Inc. and Evofem Biosciences, Inc

Merger Agreements

ADiTx Therapeutics, Inc.

2024

Agreement and Plan of Merger, dated August 5, 2021, by and among EQRx, Inc. (f/k/a CM Life Sciences III Inc.), Clover III Merger Sub Inc. and EQRx International, Inc. (f/k/a EQRx,...

Merger Agreements

Revolution Medicines, Inc.

2024

Agreement and Plan of Merger between the Company, Kinnate and Merger Sub, dated February 16, 2024

Merger Agreements

XOMA Corp

2024

Agreement and Plan of Merger, dated February 16, 2024, by and among XOMA Corporation, XRA 1 Corp. and Kinnate Biopharma Inc

Merger Agreements

Kinnate Biopharma Inc.

2024

Agreement and Plan of Merger, dated February 11, 2024, among CymaBay Therapeutics, Inc., Gilead Sciences, Inc. and Pacific Merger Sub, Inc

Merger Agreements

Gilead Sciences

2024

Second Amendment to Agreement and Plan of Merger dated as of January 8, 2024, by and among Aditxt, Inc., Adicure, Inc. and Evofem Biosciences, Inc

Merger Agreements

ADiTx Therapeutics, Inc.

2024